Michelle Nuno, PhD

Assistant Professor of Clinical Population and Public Health Sciences

Image of Michelle Nuno, PhD
Is this your profile? Click to edit

Overview

I am an Assistant Professor of Clinical Population and Public Health Sciences in the Division of Biostatistics at the University of Southern California. I received a B.S. in Applied Mathematics from the University of California, Riverside in 2015. I then went on to complete my graduate work at the University of California, Irvine, where I received an M.S in Statistics in 2017 and a Ph.D. in Statistics in 2020. My research interests include clinical trials and the development of robust statistical methodology for efficient sampling designs. I am particularly interested in biomedical applications in Alzheimer’s disease and pediatric oncology.

Awards

  • University of California, Irvine: Carl Cotman Young Investigator Award (UCI MIND), 2020
  • University of California, Irvine: Information and Computer Science Latino Excellence Award, 2019
  • University of California, Irvine: National Science Foundation Graduate Research Fellowship Program, 2017
     – 2020
  • University of California, Irvine: Achievement Rewards for College Scientists Scholar, 2017
     – 2019
  • University of California, Irvine: Robert L. Newcomb Memorial Endowed Graduate Student Award- UCI Statistics, 2016
  • University of California, Irvine: Eugene Cota Robles Fellowship, 2015
     – 2020
  • University of California, Irvine: Provost Ph.D. Fellow, 2015

Education and Training

  • University of California, Riverside, Riverside, CA — B.S. — 06/2015 — Applied Mathematics
  • University of California, Irvine, Irvine, CA — M.S. — 06/2017 — Statistics
  • University of California, Irvine, Irvine, CA — Ph.D. — 06/2020 — Statistics

Research Keywords

  • Survival analysis
  • Efficient sampling designs
  • Model misspecification
  • pediatric oncology
  • Alzheimer's disease

Publications

  • Second Malignancies in Children and Adolescents With Extracranial Germ Cell Tumors: A Report From the Malignant Germ Cell Tumor International Consortium. Pediatr Blood Cancer. 2026 May; 73(5):e70206.. View in PubMed
  • Vaginal germ cell tumors: results from the international retrospective VAGIPED study. Br J Cancer. 2025 Dec; 133(11):1668-1674.. View in PubMed
  • Characteristics of Health Care Settings Where Adolescents and Young Adults Receive Care for ALL. JCO Oncol Pract. 2024 04; 20(4):491-502.. View in PubMed
  • Characterizing Lymphovascular Invasion in Pediatric and Adolescent Malignant Ovarian Nongerminomatous Germ Cell Tumors: A Report from the Children’s Oncology Group. J Pediatr Surg. 2023 Dec; 58(12):2399-2404.. View in PubMed
  • Refining the serum miR-371a-3p test for viable germ cell tumor detection. Sci Rep. 2023 06 29; 13(1):10558.. View in PubMed
  • Refining the serum miR-371a-3p test for viable germ cell tumor detection: identification and definition of an indeterminate range. Res Sq. 2023 Mar 21.. View in PubMed
  • Growth Hormone Deficiency in Childhood Intracranial Germ Cell Tumor Survivors. J Endocrinol Metab. 2022 Jun; 12(3):79-88.. View in PubMed
  • Censoring-robust time-dependent receiver operating characteristic curve estimators. Stat Med. 2021 12 30; 40(30):6885-6899.. View in PubMed
  • A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis. Clin Genitourin Cancer. 2021 12; 19(6):469-479.. View in PubMed
  • On the design of early-phase Alzheimer’s disease clinical trials with cerebrospinal fluid tau outcomes. Clin Trials. 2021 12; 18(6):714-723.. View in PubMed